Применение программы вспомогательных репродуктивных технологий у пациентки с системной красной волчанкой и антифосфолипидным синдромом

1. Østensen M. Sexual and reproductive health in rheumatic disease. Nat. Rev. Rheumatol. 2017; 13(8): 85-93. https://dx.doi.org/10.1038/nrrheum.2017.102.
2. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum. 1999; 42(9): 1785-96. https://dx.doi.org/10.1002/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#.
3. Baker W.F. Jr, Bick R.L. The clinical spectrum of antiphospholipid syndrome. Hematol. Oncol. Clin. North Am. 2008; 22(1): 33-52, v-vi. https://dx.doi.org/10.1016/j.hoc.2007.10.007.
4. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N. Engl. J. Med. 2008; 358(9): 929-39. https://dx.doi.org/10.1056/NEJMra071297.

5. Насонов Е.Л., ред. Ревматология. Российские клинические рекомендации. М.: ГЭОТАР-Медиа; 2017. 456 с.

6. Lahita R.G. The role of sex hormones in systemic lupus erythematosus. Curr. Opin. Rheumatol. 1999;11(5): 352-6. https://dx.doi.org/10.1097/00002281-199909000-00005.
7. Oktem O., Hande Y., Hale B., Bulent U. Reproductive aspects of systemic lupus erythematosus. J. Reprod. Immunol. 2016; 117: 57-65. https://dx.doi.org/10.1016/j.jri.2016.07.001.
8. Lee T.P., Chiang B.L. Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun. Rev. 2012; 11(6-7): A422-9. https://dx.doi.org/10.1016/j.autrev.2011.11.020.
9. Andreoli L., Crisafulli F., Tincani A. Pregnancy and reproductive aspects of systemic lupus erythematosus. Curr. Opin. Rheumatol. 2017; 29(5): 473-9. https://dx.doi.org/10.1097/BOR.0000000000000415.
10. Clowse M.E., Chakravarty E., Costenbader K.H., Chambers C., Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. (Hoboken). 2012; 64(5): 668-74. https://dx.doi.org/10.1002/acr.21593.
11. Lawrenz B., Henes J., Henes M., Neunhoeffer E., Schmalzing M., Fehm T. et al. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus. 2011; 20(11): 1193-7. https://dx.doi.org/10.1177/0961203311409272.
12. Medeiros P.B., Febronio M.V., Bonfa E., Borba E.F., Takiuti A.D., Silva C.A. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus. 2009;18(1): 38-43. https://dx.doi.org/10.1177/0961203308094652.
13. LaBarbera A.R., Miller M.M., Ober C., Rebar R.W.. Autoimmune etiology in premature ovarian failure. Am. J. Reprod. Immunol. Microbiol. 1988; 16(3): 115-22.
14. Blanco-Favela F., Quintal-Alvarez G., Leanos-Miranda A. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. J. Rheumatol. 1999; 26(1): 55-9.
15. Silva C.A., Deen M.E., Febronio M.V., Oliveira S.K., Terreri M.T., Sacchetti, S.B. et al. Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea. Rheumatol. Int. 2011; 31(8): 1037-43. https://dx.doi.org/10.1007/s00296-010-1389-2.
16. Ioannidis J.P., Katsifis G.E., Tzioufas A.G., Moutsopoulos H.M. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J. Rheumatol. 2002; 29(10): 2129-35.
17. Oktem O., Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res. 2007;67(21): 10159-62. https://dx.doi.org/10.1158/0008-5472.CAN-07-2042.
18. Crawford N.M., Steiner A.Z. Age-related infertility. Obstet. Gynecol. Clin. North Am. 2015; 42(1): 15-25. https://dx.doi.org/10.1016/j.ogc.2014.09.005.
19. Levine A.B., Lockshin M.D. Assisted reproductive technology in SLE and APS. Lupus. 2014; 23(12): 1239-41. https://dx.doi.org/10.1177/0961203314527370.
20. Reynaud Q., Lega J.C., Mismetti P., Chapelle C., Wahl D., Cathebras P., Laporte S. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev. 2014; 13(6): 595-608. https://dx.doi.org/10.1016/j.autrev.2013.11.004.
21. Bellver J., Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil. Steril. 2009; 92(6): 1803-10. https://dx.doi.org/10.1016/j.fertnstert.2009.06.033.
22. Reggia R., Sebbar H., Andreoli L. et al. Infertility and assisted reproductive technologies: a multicenter study in patients with SLE and APS. Clin. Exp. Rheumatol. 2016; 34(4, Suppl.99): P1:05, S-50. (10th European Lupus Meeting – Abstracts Venice, Italy - 5-8 October 2016)
23. Henriksson P., Westerlund E., Wallén H., Brandt L., Hovatta O., Ekbom A. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2015; 346: e8632. https://dx.doi.org/10.1136/bmj.e8632.
24. Andreoli L., Bertsias G.K., Agmon-Levin N., Brown S., Cervera R., Costedoat-Chalumeau N. et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome, Ann. Rheum. Dis. 2017; 76(3): 476-85. https://dx.doi.org/10.1136/annrheumdis-2016-209770.

Поступила 04.02.2020

Принята в печать 07.02.2020